HomeKPTI • NASDAQ
Follow
Karyopharm Therapeutics Inc
Previous close
$1.48
Day range
$1.43 - $1.60
Year range
$0.62 - $4.87
Market cap
173.75M USD
Avg Volume
1.39M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 33.75M | 0.50% |
Operating expense | 169.44M | -9.30% |
Net income | -41.84M | -8.65% |
Net profit margin | -123.97 | -8.11% |
Earnings per share | -0.36 | 16.28% |
EBITDA | -37.73M | -1.27% |
Effective tax rate | -0.31% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 191.44M | -31.13% |
Total assets | 240.44M | -32.87% |
Total liabilities | 376.64M | 0.48% |
Total equity | -136.21M | — |
Shares outstanding | 115.07M | — |
Price to book | -1.24 | — |
Return on assets | -37.04% | — |
Return on capital | -49.37% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -41.84M | -8.65% |
Cash from operations | -18.58M | 30.76% |
Cash from investing | 26.84M | 141.11% |
Cash from financing | 264.00K | -99.83% |
Net change in cash | 8.61M | -86.51% |
Free cash flow | -2.32M | 83.89% |
About
Founded
2008
Headquarters
Website
Employees
325